Alto Neuroscience, Inc.
ANRO
$34.20
-$1.61-4.50%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 243.73M | 263.76M | 176.48M | 137.82M | 147.59M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.59M | 5.36M | 1.23M | 1.63M | 2.26M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 247.32M | 269.13M | 177.72M | 139.45M | 149.85M |
|
|
|||||
| Total Current Assets | 247.32M | 269.13M | 177.72M | 139.45M | 149.85M |
| Net Property, Plant & Equipment | 5.91M | 6.30M | 6.13M | 6.49M | 6.96M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 838.00K | 838.00K | 838.00K | 1.07M | 1.07M |
| Total Assets | 254.07M | 276.26M | 184.69M | 147.01M | 157.88M |
|
|
|||||
| Total Accounts Payable | 4.02M | 3.37M | 1.88M | 2.06M | 1.67M |
| Total Accrued Expenses | 7.50M | 6.31M | 7.71M | 5.87M | 5.49M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.13M | 3.44M | 1.74M | 1.12M | 973.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 16.65M | 13.12M | 11.33M | 9.05M | 8.13M |
|
|
|||||
| Total Current Liabilities | 16.65M | 13.12M | 11.33M | 9.05M | 8.13M |
| Long-Term Debt | 14.88M | 16.22M | 18.40M | 22.44M | 22.12M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.28M | 3.56M | 3.82M | 3.97M | 4.21M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 34.82M | 32.89M | 33.55M | 35.45M | 34.47M |
|
|
|||||
| Common Stock & APIC | 474.74M | 471.23M | 352.75M | 297.00M | 294.65M |
| Retained Earnings | -255.51M | -227.87M | -201.63M | -185.45M | -171.27M |
| Treasury Stock & Other | 17.00K | 13.00K | 22.00K | 14.00K | 31.00K |
| Total Common Equity | 219.25M | 243.37M | 151.14M | 111.56M | 123.41M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 219.25M | 243.37M | 151.14M | 111.56M | 123.41M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 219.25M | 243.37M | 151.14M | 111.56M | 123.41M |
|
|
|||||